12:00 AM
 | 
Mar 20, 2000
 |  BC Week In Review  |  Company News  |  Deals

Insmed Pharmaceuticals, Taisho deal

Insmed signed a letter of intent to grant Taisho exclusive development and commercialization rights to Insmed's INS-1 compound in Japan and...

Read the full 81 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >